JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.28% |
| 2 | Technology | 15.04% |
| 3 | Healthcare | 12.52% |
| 4 | Financials | 10.55% |
| 5 | Consumer Discretionary | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4451
Senseonics Holdings Inc
SENS
$526M
| $420K | ﹤0.01% |
20,382
+4,380
| +27% | +$114K |
2017 Q4
18 quarters
|
|
4452
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.85B
| $418K | ﹤0.01% |
8,705
-12
| -0.1% | -$604 |
2020 Q1
9 quarters
|
|
4453
PUT
Bausch Health
BHC
$2.14B
| $418K | ﹤0.01% |
+50,000
| New | +$699K |
2022 Q2
0 quarters
|
|
|
APPH
4454
DELISTED
AppHarvest, Inc. Common Stock
APPH
| $418K | ﹤0.01% |
119,918
-27,170
| -18% | -$97.4K |
2020 Q4
6 quarters
|
|
4455
Eterna Therapeutics
ERNA
$3.5M
| $416K | ﹤0.01% |
107
-3
| -3% | -$21.5K |
2021 Q2
4 quarters
|
|
4456
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$545M
| $414K | ﹤0.01% |
3,072
+1,247
| +68% | +$212K |
2021 Q1
5 quarters
|
|
|
SQZ
4457
DELISTED
SQZ Biotechnologies Company
SQZ
| $414K | ﹤0.01% |
130,247
+13,016
| +11% | +$46.8K |
2020 Q4
6 quarters
|
|
4458
Hackett Group
HCKT
$268M
| $413K | ﹤0.01% |
21,827
-7,215
| -25% | -$155K |
2015 Q4
26 quarters
|
|
|
CYXT
4459
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
| $413K | ﹤0.01% |
36,460
+26,389
| +262% | +$340K |
2021 Q4
2 quarters
|
|
|
BTRS
4460
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
| $413K | ﹤0.01% |
83,199
+16,835
| +25% | +$96.8K |
2021 Q2
4 quarters
|
|
4461
FuboTV Inc
FUBO
$260M
| $412K | ﹤0.01% |
13,901
+4,130
| +42% | +$192K |
2020 Q4
6 quarters
|
|
4462
MVB Financial
MVBF
$395M
| $412K | ﹤0.01% |
13,255
-5,046
| -28% | -$190K |
2018 Q2
16 quarters
|
|
|
FRBK
4463
DELISTED
Republic First Bancorp Inc
FRBK
| $411K | ﹤0.01% |
107,816
+86,817
| +413% | +$370K |
2017 Q4
18 quarters
|
|
4464
Butterfly Network
BFLY
$2.34B
| $410K | ﹤0.01% |
133,617
+18,573
| +16% | +$64.1K |
2021 Q1
5 quarters
|
|
4465
Bank First Corp
BFC
$1.68B
| $409K | ﹤0.01% |
5,405
-3,209
| -37% | -$231K |
2019 Q1
13 quarters
|
|
4466
Anavex Life Sciences
AVXL
$170M
| $408K | ﹤0.01% |
40,695
-785
| -2% | -$7.44K |
2019 Q2
12 quarters
|
|
|
FINV
4467
FinVolution Group
FINV
$694M
| $408K | ﹤0.01% |
85,869
-41,025
| -32% | -$165K |
2017 Q4
18 quarters
|
|
4468
PUT
Truist Financial
TFC
$56.7B
| $408K | ﹤0.01% |
8,600
| – | – |
2022 Q1
1 quarter
|
|
4469
Alto Ingredients
ALTO
$297M
| $407K | ﹤0.01% |
109,861
-103,913
| -49% | -$543K |
2021 Q1
5 quarters
|
|
4470
Battalion Oil
BATL
$59M
| $406K | ﹤0.01% |
47,638
-100,612
| -68% | -$1.62M |
2020 Q1
9 quarters
|
|
4471
ProShares Short S&P500
SH
$957M
| $406K | ﹤0.01% |
6,144
+2,313
| +60% | +$143K |
2018 Q3
15 quarters
|
|
4472
Tencent Music
TME
$12.6B
| $406K | ﹤0.01% |
80,819
-1,726,865
| -96% | -$7.62M |
2019 Q4
10 quarters
|
|
|
WNS
4473
DELISTED
WNS Holdings
WNS
| $405K | ﹤0.01% |
5,416
+1,201
| +28% | +$91.8K |
2016 Q3
23 quarters
|
|
|
HYZN
4474
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
| $405K | ﹤0.01% |
2,755
+1,111
| +68% | +$235K |
2021 Q1
5 quarters
|
|
4475
WisdomTree US Total Dividend Fund
DTD
$1.63B
| $404K | ﹤0.01% |
6,976
| – | – |
2018 Q2
16 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,728 reduced and 609 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 609 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.